Different Ozone Concentrations for Knee Osteoarthritis
Key facts
- Who runs it
- Sakarya University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 159 people enrolled
- Started
- 2 May 2023
- Ended
- 3 Jun 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- ozone injection
- Record updated
- 23 June 2026
Who can take part
- Age
- 50 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (2)Hide the full registry criteria
Who can take part
- Patients aged 50-85 years with a diagnosis of primary knee osteoarthritis according to the American College of Rheumatology [12] criteria, symptomatic knee with KL [13] grades II, III and IV, who underwent intra-articular ozone treatment
Who cannot take part
- Patients with a history of any intra-articular injection within 3 months before the first ozone injection, a history of previous knee surgery, a diagnosis of malignancy, missing follow-up parameters, bilateral intra-articular knee ozone injection, a secondary knee osteoarthritis diagnosis (trauma, inflammatory joint disease, etc.), patients without demographic and clinical data, or direct radiographs
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Knee osteoarthritis is a common condition that causes pain, stiffness, and difficulty with daily activities. Ozone injection therapy is a minimally invasive treatment that has been increasingly used to relieve symptoms in people with knee osteoarthritis. However, it is not clear whether different ozone concentrations produce different treatment outcomes.
Read full original descriptionShow less
In this study, we compared the effects of two commonly used ozone concentrations (15 μg/mL and 25 μg/mL) in patients with knee osteoarthritis. A total of 159 patients received intra-articular ozone injections and were followed for 3 months. Pain, physical function, and quality of life were assessed before treatment and at 1 and 3 months after the injections.
The 2 groups in the trial
- 15 μg/ml-10 ml ozone (Group A)Existing treatment, for comparison
Treatment: ozone injection
- 25 μg/ml-10 ml ozone (Group B)Existing treatment, for comparison
Treatment: ozone injection
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Is Intra-articular Injection of High-concentration Ozone (O2-O3) More Effective in Treating Knee Osteoarthritis?: A Multicenter Clinical Trial
- Record updated
- 23 June 2026